Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
Status:
COMPLETED
Trial end date:
2024-05-28
Target enrollment:
Participant gender:
Summary
This study aims to determine the efficacy of nebulising 3% hypertonic saline in improving clinical symptoms and reducing the length of hospital stay in infants with acute bronchiolitis.